Figure 3From: Assessing the quality of anti-malarial drugs from Gabonese pharmacies using the MiniLab®: a field studyThe suspect Maloxine® sample, having failed semi-quantitative thin-layer chromatography. The manufacturer is wrong to allege that it is the “only single dose treatment of malaria”.Back to article page